[chart]investorshub.advfn.com/uimage/uploads/2017/6/28/lmzwbrabits.jpg[/chart]
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NTRR. Lookin Very Nice.
Neutras National Sales Team Gets Encouraging Reception at Several Large Retail Chains
9:12 AM ET 1/14/21 | GlobeNewswire
Neutra's National Sales Team Gets Encouraging Reception at Several Large Retail Chains
Katy, TX, Jan. 14, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neutra Corporation's (OTC PINK:NTRR) new national sales team reports it has received solid interest in VIVIS' transdermal CBD products from multiple well-known nationwide and regional retail chains.
"Large retailers are seeing the success smaller outfits are having with hemp-based CBD," said Neutra CEO Sydney Jim. "Now they want a piece of that action. VIVIS can give them that opening. The chains had a positive impression of our brand and the transdermal samples we provided. The stores particularly appreciated VIVIS' insistence on testing and quality, which, of course, is our primary market differentiator. We're optimistic about future co-operation and sales opportunities."
Unlike CBD derived from cannabis, hemp-based CBD, such as that used by VIVIS, does not produce a high. This makes it legal for use in many states that outlaw cannabis. Large retail chains can stock and sell hemp-based CBD products, like transdermal creams and ointments, without worry about potential legal implications. And the fact that VIVIS lab tests each batch of product to assure potency, purity and quality should be appealing to major chains and their customers, especially those customers hesitant to enter a CBD store.
Demand for hemp-based CBD products continues its upward trend. According to market research group Brightfield, 40 percent of existing CBD users said they have increased their consumption in recent months. Prices from premium products have fallen, making quality offerings, such as those sold by VIVIS, more affordable for a greater number of buyers. Having its products stocked at major retail chains could bring in new customers who have never tried a hemp-based CBD product and greatly expand VIVIS' market share.
To learn more about VIVIS hemp-based CBD products, visit the company's website at https://viviscorp.com. After the migration of our new website, our site will return to http://viviscbd.com.
About Neutra Corp.
Neutra Corp. (NTRR) is an early-stage research and development company with a focus on bringing modern healthy living solutions to a multibillion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture-one where in which consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical sub-markets is the new thriving hemp-based CBD market, in which the Company intends to participate. For more information, visit the Company's website at http://www.NeutraInc.com.
NOTICE REGARDING FORWARD LOOKING STATEMENT
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.
Neutra Contact:
Sydney Jim
888-433-4033
info@neutrainc.com
SOURCE: Neutra Corp
> Dow Jones Newswires
January 14, 2021 09:12 ET (14:12 GMT)
ALKM. All that Volume and NO Movement????
FORW. I would think that whoever was selling all those shares @.051 is feeling Very Butthurt Now!
$FORW $30,500.00 Ask Smack
Forwardly, Inc. Provides Shareholder Update
1:40 PM ET 1/4/21 | GlobeNewswire
Forwardly, Inc. Provides Shareholder Update
Boulder City, NV, Jan. 04, 2021 (GLOBE NEWSWIRE) -- George Sharp, President and CEO of Forwardly, Inc. (OTCMKT: FORW), is pleased to announce that the company's common shares have been deemed eligible by the Depository Trust Corporation ("DTC") for electronic transfer through the Deposit/Withdrawal at Custodian ("DWAC") platform.
DWAC eligibility makes Forwardly much more attractive to future investors in the company and its projects, as shares which are issued in certificate form are not accepted for deposit by most brokerage firms
Mr. Sharp also announced that the shareholder video conference call, previously scheduled for January 12, 2021 has been rescheduled to February 16, 2021 to coincide with the release of the company's annual financial report. Further details regarding the conference call will be released in a future press release.
About Forwardly, Inc.
Forwardly is an opportunity investor seeking to finance fresh ideas. The company is headed by George Sharp, a longtime whistleblower, advocate against microcap fraud, and defender of shareholder rights. In addition to his continued participation in these activities, Mr. Sharp consults to public companies, attorneys and those associated with the financial markets. He is also a former consultant to OTC Markets Group, Inc.
Safe Harbor Statement
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by the use of the words "may," "will," "should," "plans, " "expects," "anticipates," "continue," "estimates," "projects," "intends," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, the Company's ability to successfully execute its expanded business strategy, including by entering into definitive agreements with suppliers, commercial partners and customers; general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technical advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, regulatory requirements and the ability to meet them, government agency rules and changes, and various other factors beyond the Company's control.
CONTACT:
Forwardly, Inc.
1022 Nevada Highway
Boulder City, NV 89005
702-840-4433
> Dow Jones Newswires
January 04, 2021 13:40 ET (18:40 GMT)
Alkame Holdings, Inc. Corporate Update
8:00 AM ET 1/4/21 | Dow Jones
LAS VEGAS, NV / ACCESSWIRE / January 4, 2021 / Alkame Holdings, Inc. (OTC PINK:ALKM), a publicly traded health and wellness technology holding company, is taking this opportunity to provide you, our valued shareholders, with an update on the progress of the Company for 2020, and provide a current status on our various fronts.
Our Shareholders,
As Chairman of Alkame Holdings, Inc. I would like to provide an update to our valued shareholders and provide additional details about our company status.
This has been a difficult year for most companies and Alkame is no exception. We too were negatively impacted by the global COVID-19 pandemic. However, while many businesses were idle during the shutdowns, we took necessary steps to stabilize our business, making appropriate changes, and re-positioning our company for longer-term success and growth.
First, we entered the personal protection equipment (PPE) space. We felt it was our patriotic duty to try and save lives and assist our first responders and local governments. We started with hand sanitizer and went through the lengthy time and process to receive all the proper licenses and approvals. We did not rush like so many to bring an inferior product to the market. We had the foresight to realize the virus was not going away anytime soon (Bill Gates even said he believes it will continue for two more years). Even though vaccines have come to market it will take quite some time for it to be available to the masses. Regardless, the world will forever be changed and that is why we developed and brought a premium hand sanitizer ("Ice Blue") to market.
Next, we entered into a distribution agreement as well as a manufacturing agreement for the patent-pending 'Handout Protection', a single use hand wash and sanitizer packet. Long term we believe this will be a phenomenal item. We feel it is superior in many ways to what is currently in the marketplace and has a patent pending. We feel we have both ends of the high-end premium hand sanitizer space covered with our products.
Recently, we executed an exclusive distribution agreement for our premium Ice Blue gel hand sanitizer and the Handout Protection Single use hand sanitize packets for Canada. We have discussions underway with other territories and have brought on distributors in the US.
Alkame Holdings recently entered into discussions for a patent-pending next in class disposable mask that blocks nearly 100% of all airborne particulates with its five layers of filtering. This is superior to the K95 mask which only blocks 95% of the particulates. We believe this mask is a game-changer and would round out our Alkame medical division for now.
Our pipeline of opportunities is growing strong as we have signed several new food and beverage multi-year co-pack and development agreements for both CBD and non-CBD products with many more in the works.
Next, we made significant strides including management changes and additions, including a new controller and a new director of operations to aid us as we completed 2020 and assist us in preparing to kick off 2021 with the controlled growth of the numerous opportunities that appropriate infrastructure permits us to take advantage of.
The Alkame Holding's team is also in talks for several additional opportunities including our Pawz and Clawz pet brand.
Alkame Holding's Cannaribbean brand was put on hold due to the virus. The product line is now planned for launch in early 2021.
Lastly, we are also pleased to announce that our Salem facility will be completed and ready to go in the new year. It will provide us with expanded production capability for the growth we anticipate while also permitting us to become more cost effective in our production operations.
We remain enthusiastic about our business prospects and returning to growth mode. Alkame Holding's like many businesses across the United States faces challenges in this Covid-19 world and we are seeking some additional capital to support our growth but are trying to avoid "toxic" financing at all costs.
Management is confident we will return to the position we were in earlier in 2020 when our revenue growth outpaced our increasing expenses, as we are now able to achieve operating efficiencies.
We look forward to continuing to share our progress with you our valued shareholders.
Craig Kaufman - Chairman
About Alkame Holdings, Inc.
Alkame Holdings, Inc. is a publicly traded health and wellness technology holding company, with a focus on patentable, innovative, and eco-friendly consumer products. The Company's wholly owned subsidiaries manufacture products with enhanced water utilizing a proprietary technology to create products with several unique properties. The organization is diligently building a strong foundation through the launch and acquisition of appropriate business assets, and by pursuing multiple applications by placement into several emerging business sectors, such as consumer bottled water and RTD products, household pet products, horticulture and agriculture applications, hand sanitizers, and many other various water-based treatment solutions to both new and existing business platforms.
For more information, visit www.alkameholdingsinc.com.
Alkame Holdings, Inc. Investor Relations
Website: www.alkameholdingsinc.com
Email: info@alkameholdingsinc.com
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
SOURCE: Alkame Holdings, Inc.
View source version on accesswire.com:
https://www.accesswire.com/622896/Alkame-Holdings-Inc-Corporate-Update
> Dow Jones Newswires
January 04, 2021 08:00 ET (13:00 GMT
Is this ALKM Turd ever gonna Float up from the bottom of the Bowl?
Neutra Poised for Greater Growth as Another Successful Year Comes to a Close
9:32 AM ET 12/18/20 | Dow Jones
KATY, TX / ACCESSWIRE / December 18, 2020 / Neutra Corporation (OTC PINK:NTRR) has enjoyed a year of important milestones and achievements that have set up the company for a strong 2021. These accomplishments are even more impressive considering the world saw the onset of a global pandemic in March that continues to this day.
Among the biggest highlights for 2020 include:
-- a fresh influx of funding
-- the retiring of convertible debt
-- the granting of hemp processing and handling from the state of Texas
-- the opening of manufacturing facilities in the Greater Houston area
-- the rollout of several new zero-THC products, including Broad-Spectrum
CBD Products
-- expansion into equipment rental and consulting
-- and finally, the hiring of a national sales team
"It's obviously been a year of great challenges because of COVID, but thanks to careful planning and a lot of hard work, Neutra is wrapping up its most successful year to date," said CEO Sydney Jim. "I'm proud to inform our valued shareholders that we've met our goals for the year and we're aiming much higher for 2021. We're in a great position to accomplish even greater things in the coming 12 months in no small part due to our past success."
One of the items that will help Neutra get off to a good start next is a new pain cream to be produced by its VIVIS subsidiary. This pain cream will deliver superior relief for users through a broad spectrum CBD dosage of 1000 mg. The market potential for this pain cream is vast as more than 116 million Americans suffer from chronic pain issues.
To learn more about these and other VIVIS hemp-based CBD products, visit the company's website at http://viviscbd.com.
About Neutra Corp.
Neutra Corp. (NTRR) is an early-stage research and development company with a focus on bringing modern healthy living solutions to a multibillion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture-one where in which consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical sub-markets is the new thriving hemp-based CBD market, in which the Company intends to participate. For more information, visit the Company's website at http://www.NeutraInc.com.
NOTICE REGARDING FORWARD LOOKING STATEMENT
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.
Neutra Contact:
Sydney Jim
888-433-4033
info@neutrainc.com
SOURCE: Neutra Corp
View source version on accesswire.com:
https://www.accesswire.com/621525/Neutra-Poised-for-Greater-Growth-as-Another-Successful-Year-Comes-to-a-Close
> Dow Jones Newswires
December 18, 2020 09:32 ET (14:32 GMT)
Forwardly, Inc. Acquires Warrants to Purchase 500 Million Shares of Tesoro Enterprises, Inc.
9:22 AM ET 12/10/20 | GlobeNewswire
Forwardly, Inc. Acquires Warrants to Purchase 500 Million Shares of Tesoro Enterprises, Inc.
Boulder City, NV, Dec. 10, 2020 (GLOBE NEWSWIRE) -- George Sharp, President and CEO of Forwardly, Inc. (OTCMKT: FORW), announced today that the company has made a cash investment in Tesoro Enterprises, Inc. (OTCMKT: TSNP), soon to be renamed HUMBL, Inc., as one of two parties to purchase Tesoro warrants. These warrants enable Forwardly to purchase up to 500 million shares of Tesoro common stock within a period of two years. The agreement between Forwardly and Tesoro was entered into on November 23, 2020, and its closing was contingent on the completion of the merger between HUMBL and Tesoro Enterprises, Inc., which has now taken place.
According to Mr. Sharp, "HUMBL's business model and leadership in blockchain based, global payment systems made this investment especially interesting to Forwardly. The investment has already proven to be mutually beneficial. As a result of the public's enthusiasm in HUMBL's endeavors, and the fortuitous timing of the execution of the purchase agreement, the warrants negotiated by Forwardly are already well in the money, and Forwardly owns an asset currently worth over one hundred million dollars. This will provide us the leverage to raise additional funds for all of our projects at optimally attractive terms."
HUMBL, Inc. President, Brian Foote, stated, "George's assistance with the HUMBL merger and his ability to guide us through the process of being a public company made a relationship with Forwardly a natural event. We look forward to a continued relationship with him, both as an advisor to HUMBL and in his capacity as President of Forwardly."
The HUMBL investment has no effect on Forwardly's other endeavors.
Further information about Forwardly's endeavors can be obtained from the company's website www.ForwardlyPlaced.com
About HUMBL, Inc.
The mission of HUMBL(R) and HUMBL Hubs(TM) is to deliver high quality, low cost digital payments and financial services. The HUMBL network was designed to support vertical markets such as government, banking, wireless and merchants in locations like Latin America, Caribbean, Asia and Africa who are seeking to migrate to digital payment and financial technologies, to help reduce costs and improve settlement speeds for customers.
The HUMBL(R) Mobile App delivers borderless transactions, by integrating multiple currencies, payment methods, banks, blockchain and financial services providers into one-click for the customer. HUMBL(R) provides greater access and portability than US only mobile wallet providers, such as Venmo(R) and Zelle(R) and will offer a HUMBL Hubs(TM) merchant software for clients without smartphones in certain domiciles.
"We aren't building HUMBL for the 350 million customers using PayPal(R) , but for the 7 billion people for whom money moves in different pathways, formats and cost structures," according to the CEO of HUMBL, Brian Foote.
The HUMBL website features global brand videos, product tours, market research, white papers and network architecture at www.HUMBLpay.com.
About Forwardly, Inc.
Forwardly is an opportunity investor seeking to finance fresh ideas. The company is headed by George Sharp, a longtime whistleblower and advocate against microcap fraud. In addition to consulting to public companies, attorneys and those associated with the financial markets, Mr. Sharp is a former consultant to OTC Markets Group, Inc.
Safe Harbor Statement
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by the use of the words "may," "will," "should," "plans, " "expects," "anticipates," "continue," "estimates," "projects," "intends," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, the Company's ability to successfully execute its expanded business strategy, including by entering into definitive agreements with suppliers, commercial partners and customers; general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technical advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, regulatory requirements and the ability to meet them, government agency rules and changes, and various other factors beyond the Company's control.
CONTACT:
Forwardly, Inc.
1022 Nevada Highway
Boulder City, NV 89005
702-840-4433
> Dow Jones Newswires
December 10, 2020 09:22 ET (14:22 GMT)
FORW Put them all together in One Post and I will.
NEWS.....VIVIS Hires National Sales Team as New CBD Pain Cream Nears Launch Date
6:03 AM ET 12/3/20 | Dow Jones
KATY, TX / ACCESSWIRE / December 3, 2020 / Neutra Corporation (OTC PINK:NTRR) subsidiary VIVIS is ramping up efforts to enter additional regional and national markets. The company has engaged a nationwide sales team and this group will soon be able to pitch a new VIVIS-branded CBD pain cream to customers and retail outlets, which is ready to hit the market.
"This new pain cream will be quite popular with stores and consumers alike," said Neutra CEO Sydney Jim. "It delivers superior relief for users through a broad spectrum CBD dosage of 1000 mg. Chronic pain sufferers can enjoy a respite and thus be more productive in their day-to-day lives. Retailers will be able to assure customers this pain cream is a quality, lab-tested product, just like all VIVIS offerings. And thanks to our new sales organization, our new CBD pain cream will reach a broader base, giving us additional revenue opportunities and greater market share."
As mentioned, VIVIS' pain cream comes in a 1000 mg broad spectrum dosage. It will be sold in a 1.7 oz. airless pump with pricing the same as the company's popular sports menthol cream.
According to a recent study, up to 116 million Americans suffer from chronic pain. Chronic pain costs victims more than $600 million in medical expenses and lost productivity. Worse, these patients often develop tolerance for conventional anti-pain medications, weakening their effectiveness over time. Hemp-based CBD products, such as those made by VIVIS, can alleviate such pain. Unlike CBD derived from cannabis, hemp-based CBD does not produce a high, thus it is legal for use in many states that outlaw cannabis.
To learn more about these and other VIVIS hemp-based CBD products, visit the company's website at http://viviscbd.com.
About Neutra Corp.
Neutra Corp. (NTRR) is an early-stage research and development company with a focus on bringing modern healthy living solutions to a multibillion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture-one where in which consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical sub-markets is the new thriving hemp-based CBD market, in which the Company intends to participate. For more information, visit the Company's website at http://www.NeutraInc.com.
NOTICE REGARDING FORWARD LOOKING STATEMENT
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.
Neutra Contact:
Sydney Jim
888-433-4033
info@neutrainc.com
SOURCE: Neutra Corp
View source version on accesswire.com:
https://www.accesswire.com/619250/VIVIS-Hires-National-Sales-Team-as-New-CBD-Pain-Cream-Nears-Launch-Date
> Dow Jones Newswires
December 03, 2020 06:03 ET (11:03 GMT)
FORW my shares are up 2,185% I'm Rich. LOL What a Keeper
ALKM sits in the Dumpster while my other stocks go to the MOON
FORW AWSOME DAY
FORW Wait till we get 100's of millions shares traded! Gonna go Nuts.
Creig going to ruin the company, Greedy. ALKM
ALKM it will be a sad day for SH'dlrs
100's of millions
Waiting for all them shares to hit the market
FORW New 52 week High on the way.
FORW. Just wait till we get several Days of 400+ million Trading Volume.
NTRR Dow is exploding to the upside. GO NTRR
FORW, George said: A Good 4th Quarter!!!
NTRR Heating up OTCX on da bid @9
NTRR Time to Bounce.
George release the News
FORW on News Watch.
We should have SS#'s update @12:01am Tomorrow Morning from the OTCM.
Don't worry, I'm Not counting you out. If my memory is correct, you took NOBO's spot. Meaning you are the newest addition to the MOD Squad.
I don't mess with the I Box. I just sticky the recent News. I Probably will have to add New News Monday Morning.
Pretty sure the order goes. PBJ-DD-PRP(me)-than You.
Neutra Subsidiary VIVIS Inks LOI with Expanding Oklahoma Cannabis Firm
6:00 AM ET 9/16/20 | Dow Jones
Related Quotes
3:57 PM ET 9/15/20
Symbol Last % Chg
NTRR
0.00 0.00%
Real time quote.
KATY, TX / ACCESSWIRE / September 16, 2020 / Neutra Corporation (OTC PINK:NTRR) subsidiary VIVIS has signed a letter of intent (LOI) with an Oklahoma cannabis company looking to expand its operations with the help of VIVIS' expertise and network of industry contacts. This arrangement will enable VIVIS to establish a new line of revenue and could lead to the development of new CBD products.
"They're a company on the verge of something big," said Neutra CEO Sydney Jim. "They have a good foundation product-wise. What they lack are knowledge and marketplace contacts, which we can supply. Our experience and network, properly combined with their products - and new products we may jointly develop - offers both companies an opportunity to build and grow new revenue streams."
Demand for hemp-based CBD products has continued to grow, even during the ongoing COVID-19 crisis. Consumers enjoy the pain-relief benefits they receive from hemp-based CBD products as they do not produce a high as hemp does not contain THC. Market research group Brightfield reports that 40 percent of CBD users said they have increased their consumption in recent months.
In addition, prices of premium CBD products have fallen thanks to advances in production and distribution. This makes them more affordable for a greater number of buyers, leading to a wider customer base. High-quality VIVIS hemp-based products are tested by a third-party lab for purity and potency - a key differentiator for VIVIS in the market.
To learn more about these and other VIVIS hemp-based CBD products, visit the company's website at http://viviscbd.com.
About Neutra Corp.
Neutra Corp. (NTRR) is an early-stage research and development company with a focus on bringing modern healthy living solutions to a multibillion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture-one where in which consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical sub-markets is the new thriving hemp-based CBD market, in which the Company intends to participate. For more information, visit the Company's website at http://www.neutrainc.com.
NOTICE REGARDING FORWARD LOOKING STATEMENT
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.
Neutra Contact:
Sydney Jim
888-433-4033
info@neutrainc.com
SOURCE: Neutra Corp
View source version on accesswire.com:
https://www.accesswire.com/606246/Neutra-Subsidiary-VIVIS-Inks-LOI-with-Expanding-Oklahoma-Cannabis-Firm
> Dow Jones Newswires
September 16, 2020 06:00 ET (10:00 GMT)
Nice bid @.001 now L2 has shifted
NTRR I think we will get some news since the 10-Q has been posted.
Q-2 just posted. 10-Q 09/14/2020 Period end 07/31/2020
https://www.otcmarkets.com/stock/NTRR/disclosure
Need Some good News, Bring it on NTRR.
SS Updated this morning. Same as it was in January.
FORW SECURITY DETAILS
Share Structure
Market Cap Market Cap
2,663,836
08/31/2020
Authorized Shares
1,360,000,000
08/31/2020
Outstanding Shares
269,074,346
08/31/2020
Restricted
1,368,929
08/31/2020
Unrestricted
267,705,417
08/31/2020
Held at DTC
256,714,697
08/31/2020
GRDOD SECURITY DETAILS
Share Structure
Market Cap Market Cap
Not Available
Authorized Shares
1,360,000,000
01/17/2020
Outstanding Shares
269,074,092
01/17/2020
Restricted
1,368,929
01/17/2020
Unrestricted
267,705,163
01/17/2020
Held at DTC
174,845,194
01/17/2020
Wake Up We got News read last post
Forwardly, Inc. Raises $500,000 Privately; Will Fund Development of Ligand Global Innovations Latest Prototype of LifeAir G1
9:00 AM ET 8/31/20 | Dow Jones
Boulder City, Nevada--(Newsfile Corp. - August 31, 2020) - George Sharp, President and CEO of Forwardly, Inc. (OTC PINK: FORW), announced today that it has already received funding commitments of $500,000 of an anticipated total of $1.3 million in financing and will itself fund Ligand Global Innovation's ("Ligand") development of its latest prototype of the LifeAir G1 Portable Ventilator.
As announced in a June 15, 2020 press release, Forwardly, through its wholly owned subsidiary, Breathe Medical Devices, Inc., has obtained the exclusive US distribution rights to the LifeAir line of ventilator products. As part of the agreement, Forwardly also has the option to acquire up to 25% ownership interest in Ligand. Forwardly's funding of the development of the new LifeAir G1 prototype will be applied towards the exercise of this option.
More information about LifeAir G1 can be found at the Breath Medical Device's website www.BreatheMedicalDevices.com
Funding for the new LifeAir G1 prototype is being raised by Forwardly through the exercise of warrants issued to purchasers of a series of debentures issued in 2019 with an aggregate total of $300,000 (the "2020 debentures"), as well as purchasers of a new series of non-toxic debentures for an aggregate total of up to $1 million. These new debentures are convertible to common stock at $.012 and set to mature in March 2022 (the "2022 debentures").
George Sharp commented, "With the business world being slowed to a crawl as a result of the current pandemic, Forwardly management deemed it more expeditious to raise funds privately to enable the development of the next generation of LifeAir G1, rather than wait for the SEC's approval of the Regulation A+ application and the subsequent time required to fund. We found our private funders to be more than eager to participate, by exercising outstanding warrants and purchasing our new series of debentures. I am proud that our private funding sources continue to support our endeavors.
Further information about Forwardly's endeavors can be obtained from the company's website www.ForwardlyPlaced.com
Safe Harbor Statement
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by the use of the words "may," "will," "should," "plans, " "expects," "anticipates," "continue," "estimates," "projects," "intends," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, the Company's ability to successfully execute its expanded business strategy, including by entering into definitive agreements with suppliers, commercial partners and customers; general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technical advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, regulatory requirements and the ability to meet them, government agency rules and changes, and various other factors beyond the Company's control.
CONTACT:
Forwardly, Inc.
1022 Nevada Highway
Boulder City, NV 89005
702-840-4433
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/62854
> Dow Jones Newswires
August 31, 2020 09:00 ET (13:00 GMT)